Status:

COMPLETED

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Lead Sponsor:

Abarbanel Mental Health Center

Conditions:

Obsessive-Compulsive Disorder

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Objectives: To evaluate tolerability and efficacy of escitalopram treatment in high dose than 20-50 mg/d in out-patients with OCD Type of the study: Open label, prospective study. Number of patients:...

Detailed Description

Objectives: To evaluate tolerability and efficacy of escitalopram treatment in doses higher than 20mg (20-50 mg/d) in patients with OCD, non responsive or partially responsive to recommended doses. T...

Eligibility Criteria

Inclusion

  • Men and women over 18 years of age
  • DSM IV-TR criteria for OCD
  • OCD associated with most distress or most interference in the patient's life as judged by the treating physician
  • Yale-Brown Obsessive Compulsive Scale (YBOCS) total score ≥ 16

Exclusion

  • Other primary or co-primary psychiatric disorder which is more distressful for the patient then the OCD, as evaluated by investigator
  • Patients with any history of mania/bipolar disorder
  • Patients using medications which are contraindicated with the use of escitalopram
  • Known contraindication for the use of citalopram or escitalopram.
  • Unable to understand and give informed consent
  • Prominent suicidal ideation (2 points or more in the MADRS "suicidal thoughts" item)
  • Alcohol or substance dependence in the past 6 months
  • Major physical illness
  • Woman currently pregnant or less then 4 weeks after a childbirth, a woman lactating, or a woman of childbearing potential not using a medically accepted form of contraception.
  • Liver function abnormality
  • EKG abnormalities

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

End Date :

December 1 2006

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00305500

Start Date

March 1 2006

End Date

December 1 2006

Last Update

July 26 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Abarbanel MHC

Bat Yam, Israel, 59100